Breast/ovarian cancer
141 – 150 of 156
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Transcriptional profiling of breast cancer metastases identifies liver metastasis-selective genes associated with adverse outcome in luminal A primary breast cancer.
- Contribution to journal › Article
- 2015
-
Mark
Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications.
- Contribution to journal › Article
-
Mark
Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival.
- Contribution to journal › Article
-
Mark
Clinical and molecular complexity of breast cancer metastases.
- Contribution to journal › Scientific review
- 2014
-
Mark
Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes.
- Contribution to journal › Article
-
Mark
Molecular profiling of male breast cancer - Lost in translation?
- Contribution to journal › Scientific review
-
Mark
Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.
- Contribution to journal › Article
- 2013
-
Mark
The Landscape of Candidate Driver Genes Differs between Male and Female Breast Cancer.
- Contribution to journal › Article
- 2012
-
Mark
Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk
- Contribution to journal › Article
-
Mark
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker
- Contribution to journal › Article
